| Name | Boc-L-Histidine(Tosyl) |
|---|---|
| Synonyms |
NALPHA-(TERT-BUTOXYCBONYL)-T-(P-TOLUENESULFONYL)-L-HISTIDINE
N-tert-Butoxycbonyl-N-imidazole-(4-toluenesulfonyl)-L-histidine N-ALPHA-T-BOC-IM-TOSYL-L-HIS Nα-Boc-N(im)-tosyl-L-histidine Nα-Boc-Nim-4-toluenesylfonyl-L-histidine Butoxycbonyltoluenosulfonylhistidine (S)-2-((tert-Butoxycarbonyl)amino)-3-(1-tosyl-1H-imidazol-4-yl)propanoic acid Nα-(tert-Butoxycarbonyl)-τ-(p-toluenesulfonyl)-L-histidine N-ALPHA-T-BUTOXYCBONYL-N-TAU-TOSYL-L-HISTIDINE (2S)-3-[1-(4-methylphenyl)sulfonylimidazol-4-yl]-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid N-(ALPHA)-(TERT-BUTOXYCBONYL)-TAU-(P-TOLUENESULFONYL)-L-HISTIDINE H-Octyl-Gly-OH(S) MFCD00065967 Nα-Boc-Nim-4-toluenesylfonyl-L-histidine (HPLC) N-alpha-t-Butyloxycbonyl-N-im-t-tosyl-L-histidine Nalpha-Boc-tele-tosyl-L-histidine Boc-His(Tos)-OH BOC-HIS(TOS) N-ALPHA-T-BUTYLOXYCBONYL-N-IM-TOSYL-L-HISTIDINE Boc-L-Histidine(Tosyl) //BP BOC-N-IM-4-TOLUENESYLFONYL-L-HISTIDINE N^a-Boc-1-toluenesulfonyl-L-histidine N-(tert-butoxycbonyl)-im-tosyl-L-histidine (2S)-3-[1-(4-methylphenyl)sulfonylimidazol-4-yl]-2-[(2-methylpropan-2-yl)oxycbonylamino]propanoic acid NALPHA-BOC-TELE-TOSYL-L-HISTIDINE Boc-His(1-Tos)-OH N-ALPHA-BOC-NIM-TOSYL-L-HISTIDINE ISOPROPYL ALCOHOL Nalpha-(tert-Butoxycarbonyl)-tele-(p-toluenesulfonyl)-L-histidine Nα-(tert-Butoxycbonyl)-τ-(p-toluenesulfonyl)-L-histidine > Boc-L-His(Tos)-OH (R)-L-(+)-Boc-his(tos)-OH N-(tert-Butoxycarbonyl)-1-[(4-methylphenyl)sulfonyl]-L-histidine N-[(1,1-Dimethylethoxy)carbonyl]-1-[(4-methylphenyl)sulfonyl]-L-histidine 3-[1-(4-methylphenyl)sulfonyl-4-imidazolyl]-2-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]propanoic acid BOC-L-HISTIDINE(TOSYL) BOC-L-HIS(TOS) N-alpha-BOC-N(im)-tosyl-L-histidine 1-[(4-Methylphenyl)sulfonyl]-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-histidine (S)-2-(tert-butoxycbonylamino)-3-(1-tosyl-1H-imidazol-4-yl)propanoic acid (2S)-2-{[(tert-butoxy)carbonyl]amino}-3-[1-(4-methylbenzenesulfonyl)-1H-imidazol-4-yl]propanoic acid (Tert-Butoxy)carbonyl His(Tos)-OH BOC-HISTIDINE(TOS)-OH NALPHA-TERT-BUTOXYCBONYL-N(IM)-TOSYL-L-HISTIDINE N-ALPHA-BOC-N(IM)-TOSYL-L-HISTIDINE BOC-HIS(TOS)-OH IPA N ALPHA-T-BUTOXYCBONYL-N(IM)-TOSYL-L-HISTIDINE Boc-His(tau-Tos)-OH BOC-HIS(TOS)-OH N-ALPHA-T-BOC-N-IM-TOSYL-L-HISTIDINE N^(alpha)-(tert-Butoxycbonyl)-tau-(p-toluenosulfonyl)-L-histidine Boc-His(Tos)-OH >= (TLC) Boc-His(t-Tos)-OH NALPHA-tert-Butoxycbonyl-N-imidazole-(4-toluenesulfonyl)-L-histidine N-ALPHA-TERT-BUTYLOXYCBONYL-N-IM-TOSYL-L-HISTIDINE N-Boc-1-(p-toluenesulfonyl)-L-histidine NALPHA-(TERT-BUTOXYCBONYL)-TELE-(P-TOLUENESULFONYL)-L-HISTIDINE Nα-Boc-τ-tosyl-L-histidine Boc-L-Histidine(Tosy Nα-(tert-Butoxycbonyl)-τ-(p-toluenesulfonyl)-L-histidine N-ALPHA-T-BUTYLOXYCBONYL-N-TAU-TOSYL-L-HISTIDINE N-T-boc-im-tosyl-L-histidine free acid L-Histidine, N-[(1,1-diMethylethoxy)carbonyl]-1-[(4-Methylphenyl)sulfonyl] BOC-L-HIS(TOS)-OH 2-{[(tert-butoxy)carbonyl]amino}-3-{1-[(4-Methylbenzene)sulfonyl]-1H-iMidazol-4-yl}propanoic acid |
| Description | Boc-His(Tos)-OH is a histidine derivative[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1]. |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Melting Point | ~125 °C (dec.) |
| Molecular Formula | C18H23N3O6S |
| Molecular Weight | 409.457 |
| Exact Mass | 409.130768 |
| PSA | 135.97000 |
| LogP | 2.14 |
| Index of Refraction | 1.595 |
| Storage condition | −20°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | T+ |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2933290090 |
| Precursor 2 | |
|---|---|
| DownStream 3 | |
| HS Code | 2933290090 |
|---|---|
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |